Meta AnalysisID 7936
熊去氧胆酸在治疗与预防COVID-19中的作用：一项系统评价与Meta分析
CRD42023495522
What is the effectiveness of Ursodeoxycholic Acid (UDCA) in the treatment and prevention of COVID-19?
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 7936
- Evidence Id
- 16494
- Core Evidence Id
- 16494
- Source Meta Analysis Id
- 7933
- Herb2 Meta Analysis Id
- HBMA007933
- Crd Id
- CRD42023495522
- Title
- The Role of Ursodeoxycholic Acid in the Treatment and Prevention of COVID-19: A Systematic Review and Meta-Analysis
- Review Question
- What is the effectiveness of Ursodeoxycholic Acid (UDCA) in the treatment and prevention of COVID-19?
- Study Type Included
- Cohort studies will be included. Case-control studies, case reports, editorials, and reviews will be excluded.
- Condition Being Studied
- COVID-19
- Participant
- A study was considered eligible for inclusion in the analysis if it was 1) cohort study 2) reported SARS-Cov-2 infection rate of patients with UDCA therapy compared to standard treatment or placebo or reported outcomes of interest in patients with COVID-19 with UDCA therapy compared to standard treatment or placebo.
- Animal
- Human Disease Modelled
- Intervention
- The intervention of interest is the administration of Ursodeoxycholic Acid (UDCA).
- Comparator Control
- Comparators may include placebo, standard care, or other therapeutic interventions for COVID-19.
- Main Outcome
- Main outcomes will include infection rate, mortality rate, hospitalization rate, duration of hospital stay, and other effects that can reflect the therapeutic effect. Measures of effect Measures of Effect will include odds ratio, risk difference, standard mean difference.
- Outcome Measure
- Additional Outcome
- None.
- Study Method
- Intervention, Meta-analysis, Prevention, Systematic review
- Keyword
- MeSH headings have not been applied to this record
- Contact
- Guo Yu [email protected]
- Organisational Affiliation
- China Pharmaceutical University https://en.cpu.edu.cn/
- Funding Source
- Guo Yu reports receiving grants from Jiangsu Provincial Natural Science Fund for Distinguished Young Scholars (BK20200005) Grant number(s) State the funder, grant or award number and the date of award BK20200005
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- 2023-12-20
- Registration Date
- 2023-12-21
- Anticipated Start Date
- 2023-12-11
- Anticipated Completion Date
- 2024-01-20
- Title Cn
- 熊去氧胆酸在治疗与预防COVID-19中的作用：一项系统评价与Meta分析
- Title En
- The Role of Ursodeoxycholic Acid in the Treatment and Prevention of COVID-19: A Systematic Review and Meta-Analysis
- Bilingual Status
- complete